Clinical Trial Update: The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy [Phase 2]

View source ↗

Summary

This update covers a Phase 2 clinical trial evaluating the efficacy and safety of Telitacicept for primary membranous nephropathy, which is currently not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Membranous Nephropathy

Drugs mentioned

• Telitacicept

Snippet

Sponsor: Renmin Hospital of Wuhan University | Conditions: Primary Membranous Nephropathy | Phase 2 | Status: NOT_YET_RECRUITING